production commence end of q1, page-10

Writer, I think you have answered Qantum's very good question from the other day.

Sales will be brought to account during 2011 and 2012 as a result of up front licence fees from a handful from the dozen pharmas currently in discussion with UNI. Also, advance orders for the Unifill to build up inventories whilst aging in complete. Whilst SA will not want too much working capital tied up with stock sitting on the shelf, they are only 1 out of many potential UNI customers, and only a small percentage of output has been guaranteed to SA as part of the industrialisation agreement.

The size and timing of the about is uncertain, certainly will be an interesting year. IMO a re-rating by the aussie market is due and will be boosted with a take up by the Yanks.